← Back to federal legislation
S. 2121In committee

SUPPORT for Patients and Communities Reauthorization Act of 2025

Introduced: Jun 18, 2025

Latest action date: Jun 18, 2025

Your view

Current stage

In committee

The most advanced recorded stage is committee consideration.

Introduced

Jun 18, 2025

Latest action

Jun 18, 2025

Recorded roll calls

0

Civixly topics

What this legislation is about

Civixly topics make federal and state legislation comparable. They are derived from the official CRS policy area and legislative subjects.

Official CRS policy area

Health

Bill Summary

SUPPORT for Patients and Communities Reauthorization Act of 2025

This bill reauthorizes and revises Department of Health and Human Services (HHS) programs that address substance use disorders, overdoses, and mental health.

For example, the bill reauthorizes for FY2026-FY2030 grant and other programs relating to

•    addressing substance use disorders with respect to pregnant and postpartum women,
•    prevention and recovery from substance use disorders for youth, 
•    housing for individuals in recovery from substance use disorders,
•    community organizations facilitating recovery from substance use disorders,
•    loan repayment for certain health care providers treating substance use disorders, 
•    prevention of overdoses of controlled substances,
•    treatment of children experiencing psychological trauma, and
•    mental and behavioral health education and training for medical and allied health students.

Also, the bill revises several programs, including by (1) expanding a program that supports resources for first responders to include the purchase of drugs or devices to treat non-opioid overdoses, (2) expanding a program that supports employment services for individuals in recovery so as to allow for the provision of related transportation services, and (3) temporarily authorizing a regional technical assistance center to assist the National Peer-Run Training and Technical Assistance Center for Addiction Recovery Support.

Additionally, the bill establishes new requirements for HHS, including requirements relating to

•    protecting the National Suicide Prevention Lifeline program from cybersecurity threats,
•    establishing a Federal Interagency Work Group on Fentanyl Contamination of Illegal Drugs, and
•    reviewing and potentially revising the scheduling of approved products containing a combination of buprenorphine and naloxone under the Controlled Substances Act.

Committee activity

Committees and subcommittees that received, reviewed, marked up, or reported this legislation.

Amendments

Proposed changes to this measure, with their latest official outcome or action from Congress.gov.

No amendments are listed for this measure.

Checked against Congress.gov Sep 13, 2026.

Action timeline

Newest action first. Action language comes from the official Congress.gov record.

View full action timeline2 actions
  1. Introduced in Senate

    IntroReferralLibrary of Congress
  2. Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

    IntroReferralSenate

Roll-call votes

Recorded House and Senate votes connected to this bill. Your representatives appear first when available.

No connected roll-call votes are currently available for this bill.

Discussion

0 comments

Sign in to join the discussion.Comments are publicly visible.

Loading comments...

Federal legislative data comes from Congress.gov and official House and Senate vote records.

Base metadata check pending · Summary check pending · Action timeline checked Sep 13, 2026 · Complete sponsorship check pending · Topics checked Sep 13, 2026 · Committees checked Sep 13, 2026 · Status checked Sep 13, 2026 · Related bills checked Sep 13, 2026.